AR
Arrowhead Pharma
ARWR·NASDAQPasadena CAFounded 2003900 employees
Mid CapbiotechPublicCardiologyHepatologyRespiratory
Platform: RNAi TRiM
Market Cap
$5B
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ARWR)
Loading ARWR stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevimavacamten | ARW-5222 | Phase 1/2 | 2 | FcRn | CFSCD | ||
| Polanesiran | ARW-4873 | Phase 1 | 2 | CD123 | DMDSCD | ||
| Cevirasimod | ARW-7349 | Preclinical | 1 | FXIa | Ovarian Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)